Apple Health app users in the United States will soon be able to order clinical laboratory testing from Quest Diagnostics directly through their iPhones and iPads.
The collaboration will allow consumers to purchase a $119 Quest laboratory panel containing more than 50 biomarkers. The panel is intended to provide insights into cardiometabolic health and organ function, according to a Quest Diagnostics announcement.
Users will be able to schedule blood draws and biometric measurements at one of approximately 2,000 Quest patient service centers. Test results will then appear in the Apple Health app alongside other health information collected by the user’s connected devices.
Quest said it works with third-party healthcare providers to review and approve the test orders. Consumers also may request a discussion about their results and possible next steps at no additional charge.
“By embedding the Quest lab testing experience within the Apple Health app, we are making testing simpler, smarter and more available to people who want to connect biomarker and biometric insights to own their health,” said Richard Adams, senior vice president and general manager of Quest Consumer, in the announcement.
The service is expected to become available later in 2026, although Quest noted that it will not be offered in every state.
Technology companies expand into laboratory testing
The Apple collaboration is the latest indication that consumer technology companies see clinical laboratory testing as a natural extension of their health and wellness platforms.
As Dark Daily recently reported, wearable technology company WHOOP opened its Advanced Labs blood-testing service to consumers who do not own WHOOP devices. Quest also performs that testing, which starts at $150.
Both arrangements allow consumers to purchase laboratory testing outside the traditional physician-office pathway while receiving results through applications operated by non-laboratory technology companies.
For clinical laboratory professionals, the deals demonstrate how national laboratories are using partnerships with consumer brands to generate testing volume and establish direct relationships with patients. They also raise questions about who will control the presentation and interpretation of laboratory results as more testing shifts into consumer-facing digital platforms.
Apple’s large installed user base could make its arrangement with Quest particularly significant. If consumers embrace the service, other technology companies may pursue similar partnerships, creating new commercial channels for clinical laboratories while increasing competition for access to patients and their health data.
